{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:39:00Z","timestamp":1791517140255,"version":"4.3.4"},"reference-count":75,"publisher":"American Association for Cancer Research (AACR)","issue":"2","funder":[{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015338","name":"Cancer Moonshot","doi-asserted-by":"crossref","award":["P01 CA206978"],"award-info":[{"award-number":["P01 CA206978"]}],"id":[{"id":"10.13039\/100015338","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015338","name":"Cancer Moonshot","doi-asserted-by":"crossref","award":["R01CA216273"],"award-info":[{"award-number":["R01CA216273"]}],"id":[{"id":"10.13039\/100015338","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Transformation to aggressive disease histologies generates formidable clinical challenges across cancers, but biological insights remain few. We modeled the genetic heterogeneity of chronic lymphocytic leukemia (CLL) through multiplexed in vivo CRISPR-Cas9 B-cell editing of recurrent CLL loss-of-function drivers in mice and recapitulated the process of transformation from indolent CLL into large cell lymphoma [i.e., Richter syndrome (RS)]. Evolutionary trajectories of 64 mice carrying diverse combinatorial gene assortments revealed coselection of mutations in Trp53, Mga, and Chd2 and the dual impact of clonal Mga\/Chd2 mutations on E2F\/MYC and interferon signaling dysregulation. Comparative human and murine RS analyses demonstrated tonic PI3K signaling as a key feature of transformed disease, with constitutive activation of the AKT and S6 kinases, downmodulation of the PTEN phosphatase, and convergent activation of MYC\/PI3K transcriptional programs underlying enhanced sensitivity to MYC\/mTOR\/PI3K inhibition. This robust experimental system presents a unique framework to study lymphoid biology and therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Mouse models reflective of the genetic complexity and heterogeneity of human tumors remain few, including those able to recapitulate transformation to aggressive disease histologies. Herein, we model CLL transformation into RS through multiplexed in vivo gene editing, providing key insight into the pathophysiology and therapeutic vulnerabilities of transformed disease.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 101<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-22-0082","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T10:13:21Z","timestamp":1670235201000},"page":"150-169","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["<i>In Vivo<\/i>\n                    Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1573-8799","authenticated-orcid":false,"given":"Elisa","family":"ten Hacken","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-8517","authenticated-orcid":false,"given":"Tomasz","family":"Sewastianik","sequence":"additional","affiliation":[{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"3Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"4Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-5238","authenticated-orcid":false,"given":"Shanye","family":"Yin","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-898X","authenticated-orcid":false,"given":"Gabriela Brunsting","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-3449","authenticated-orcid":false,"given":"Michaela","family":"Gruber","sequence":"additional","affiliation":[{"name":"5CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3808-0811","authenticated-orcid":false,"given":"Kendell","family":"Clement","sequence":"additional","affiliation":[{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"7Molecular Pathology Unit, Center for Cancer Research and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts."},{"name":"8Department of Pathology, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0207","authenticated-orcid":false,"given":"Livius","family":"Penter","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"9Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Berlin, Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin (corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin), Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-5288","authenticated-orcid":false,"given":"Robert A.","family":"Redd","sequence":"additional","affiliation":[{"name":"10Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-9503","authenticated-orcid":false,"given":"Neil","family":"Ruthen","sequence":"additional","affiliation":[{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-7992","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Hergalant","sequence":"additional","affiliation":[{"name":"12Inserm UMRS1256 Nutrition-G\u00e9n\u00e9tique et Exposition aux Risques Environnementaux (N-GERE), Universit\u00e9 de Lorraine, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8090-7793","authenticated-orcid":false,"given":"Alanna","family":"Sholokhova","sequence":"additional","affiliation":[{"name":"13Department of Applied Mathematics, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-6691","authenticated-orcid":false,"given":"Geoffrey","family":"Fell","sequence":"additional","affiliation":[{"name":"10Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-9769","authenticated-orcid":false,"given":"Erin M.","family":"Parry","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"14Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-4006","authenticated-orcid":false,"given":"Julien","family":"Bros\u00e9us","sequence":"additional","affiliation":[{"name":"12Inserm UMRS1256 Nutrition-G\u00e9n\u00e9tique et Exposition aux Risques Environnementaux (N-GERE), Universit\u00e9 de Lorraine, Nancy, France."},{"name":"15Universit\u00e9 de Lorraine, CHRU-Nancy, Service d'H\u00e9matologie Biologique, P\u00f4le Laboratoires, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7563-580X","authenticated-orcid":false,"given":"Romain","family":"Guieze","sequence":"additional","affiliation":[{"name":"16CHU Clermont Ferrand, Clermont Ferrand, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4388-0349","authenticated-orcid":false,"given":"Fabienne","family":"Lucas","sequence":"additional","affiliation":[{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"17Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9968-2782","authenticated-orcid":false,"given":"Mar\u00eda","family":"Hern\u00e1ndez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"18Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-3791","authenticated-orcid":false,"given":"Kaitlyn","family":"Baranowski","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3025-9406","authenticated-orcid":false,"given":"Jackson","family":"Southard","sequence":"additional","affiliation":[{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5328-1772","authenticated-orcid":false,"given":"Heather","family":"Joyal","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-2258","authenticated-orcid":false,"given":"Leah","family":"Billington","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1549-9495","authenticated-orcid":false,"given":"Fara Faye D.","family":"Regis","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-4066","authenticated-orcid":false,"given":"Elizabeth","family":"Witten","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-0705","authenticated-orcid":false,"given":"Mohamed","family":"Uduman","sequence":"additional","affiliation":[{"name":"10Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-9956","authenticated-orcid":false,"given":"Binyamin A.","family":"Knisbacher","sequence":"additional","affiliation":[{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"19Cancer Research Center, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-6141","authenticated-orcid":false,"given":"Shuqiang","family":"Li","sequence":"additional","affiliation":[{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-9934","authenticated-orcid":false,"given":"Haoxiang","family":"Lyu","sequence":"additional","affiliation":[{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3375-6985","authenticated-orcid":false,"given":"Tiziana","family":"Vaisitti","sequence":"additional","affiliation":[{"name":"20Department of Medical Sciences, University of Torino, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-5036","authenticated-orcid":false,"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[{"name":"20Department of Medical Sciences, University of Torino, Turin, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0864","authenticated-orcid":false,"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"21Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2190-3527","authenticated-orcid":false,"given":"Pierre","family":"Feugier","sequence":"additional","affiliation":[{"name":"12Inserm UMRS1256 Nutrition-G\u00e9n\u00e9tique et Exposition aux Risques Environnementaux (N-GERE), Universit\u00e9 de Lorraine, Nancy, France."},{"name":"15Universit\u00e9 de Lorraine, CHRU-Nancy, Service d'H\u00e9matologie Biologique, P\u00f4le Laboratoires, Nancy, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-9296","authenticated-orcid":false,"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"22Department III of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9503-1226","authenticated-orcid":false,"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[{"name":"22Department III of Internal Medicine III, Division of CLL, Ulm University, Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-2003","authenticated-orcid":false,"given":"Matthew S.","family":"Davids","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"14Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"23Cancer Center and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-5856","authenticated-orcid":false,"given":"Kenneth J.","family":"Livak","sequence":"additional","affiliation":[{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"11Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2761-825X","authenticated-orcid":false,"given":"Ivana","family":"Bozic","sequence":"additional","affiliation":[{"name":"13Department of Applied Mathematics, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"10Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6849-1852","authenticated-orcid":false,"given":"Ruben D.","family":"Carrasco","sequence":"additional","affiliation":[{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"3Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"17Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Harvard Medical School, Boston, Massachusetts."},{"name":"6Broad Institute of MIT and Harvard, Cambridge, Massachusetts."},{"name":"14Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"2025112416562028700_bib1","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2021011993","article-title":"Understanding CLL biology through mouse models of human genetics","volume":"138","author":"Ten Hacken","year":"2021","journal-title":"Blood"},{"key":"2025112416562028700_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"key":"2025112416562028700_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2021.02.003","article-title":"A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation","volume":"39","author":"Lazarian","year":"2021","journal-title":"Cancer Cell"},{"key":"2025112416562028700_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccell.2018.12.013","article-title":"A murine model of chronic lymphocytic leukemia based on B Cell-restricted expression of Sf3b1 mutation and Atm deletion","volume":"35","author":"Yin","year":"2019","journal-title":"Cancer Cell"},{"key":"2025112416562028700_bib5","doi-asserted-by":"crossref","first-page":"IJH09","DOI":"10.2217\/ijh-2018-0010","article-title":"Current trends in the management of Richter's syndrome","volume":"7","author":"Allan","year":"2018","journal-title":"Int J Hematol Oncol"},{"key":"2025112416562028700_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"key":"2025112416562028700_bib7","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"key":"2025112416562028700_bib8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"2025112416562028700_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"2025112416562028700_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"2025112416562028700_bib11","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"2025112416562028700_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2025112416562028700_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","article-title":"Evolutionary","volume":"29","author":"Parry","year":"2023","journal-title":"Nat Med"},{"key":"2025112416562028700_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13059-020-02174-1","article-title":"High throughput single-cell detection of multiplex CRISPR-edited gene modifications","volume":"21","author":"Ten Hacken","year":"2020","journal-title":"Genome Biol"},{"key":"2025112416562028700_bib15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"key":"2025112416562028700_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41467-022-34642-6","article-title":"Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis","volume":"14","author":"Broseus","year":"2023","journal-title":"Nat Commun"},{"key":"2025112416562028700_bib17","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1158\/1541-7786.MCR-19-0657","article-title":"Multi-omics analysis identifies MGA as a negative regulator of the MYC pathway in lung adenocarcinoma","volume":"18","author":"Llabata","year":"2020","journal-title":"Mol Cancer Res"},{"key":"2025112416562028700_bib18","doi-asserted-by":"crossref","first-page":"e64212","DOI":"10.7554\/eLife.64212","article-title":"Loss of MGA repression mediated by an atypical polycomb complex promotes tumor progression and invasiveness","volume":"10","author":"Mathsyaraja","year":"2021","journal-title":"eLife"},{"key":"2025112416562028700_bib19","doi-asserted-by":"crossref","first-page":"eabh3635","DOI":"10.1126\/sciadv.abh3635","article-title":"A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression","volume":"8","author":"Holmes","year":"2022","journal-title":"Sci Adv"},{"key":"2025112416562028700_bib20","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1073\/pnas.83.19.7410","article-title":"Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen","volume":"83","author":"Bishop","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416562028700_bib21","doi-asserted-by":"crossref","first-page":"W206","DOI":"10.1093\/nar\/gkz332","article-title":"Cistrome-GO: a web server for functional enrichment analysis of transcription factor ChIP-seq peaks","volume":"47","author":"Li","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025112416562028700_bib22","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel richter syndrome xenograft models to study genetic architecture, biology, and therapy responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res"},{"key":"2025112416562028700_bib23","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood.2020008404","article-title":"ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models","volume":"137","author":"Vaisitti","year":"2021","journal-title":"Blood"},{"key":"2025112416562028700_bib24","doi-asserted-by":"crossref","first-page":"e00822","DOI":"10.7554\/eLife.00822","article-title":"A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis","volume":"2","author":"Olive","year":"2013","journal-title":"eLife"},{"key":"2025112416562028700_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat Immunol"},{"key":"2025112416562028700_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20150537","article-title":"Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells","volume":"213","author":"Getahun","year":"2016","journal-title":"J Exp Med"},{"key":"2025112416562028700_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"2025112416562028700_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2018.06.052","article-title":"A Single-cell atlas of in vivo mammalian chromatin accessibility","volume":"174","author":"Cusanovich","year":"2018","journal-title":"Cell"},{"key":"2025112416562028700_bib29","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/2159-8290.CD-21-0276","article-title":"Longitudinal single-cell dynamics of chromatin accessibility and mitochondrial mutations in chronic lymphocytic leukemia mirror disease history","volume":"11","author":"Penter","year":"2021","journal-title":"Cancer Discov"},{"key":"2025112416562028700_bib30","doi-asserted-by":"crossref","first-page":"26ra5","DOI":"10.1126\/scitranslmed.3000251","article-title":"Airway PI3K pathway activation is an early and reversible event in lung cancer development","volume":"2","author":"Gustafson","year":"2010","journal-title":"Sci Transl Med"},{"key":"2025112416562028700_bib31","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature04296","article-title":"Oncogenic pathway signatures in human cancers as a guide to targeted therapies","volume":"439","author":"Bild","year":"2006","journal-title":"Nature"},{"key":"2025112416562028700_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature13906","article-title":"Rapid modelling of cooperating genetic events in cancer through somatic genome editing","volume":"516","author":"Sanchez-Rivera","year":"2014","journal-title":"Nature"},{"key":"2025112416562028700_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature13589","article-title":"CRISPR-mediated direct mutation of cancer genes in the mouse liver","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"2025112416562028700_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nbt.3155","article-title":"Inducible in vivo genome editing with CRISPR-Cas9","volume":"33","author":"Dow","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2025112416562028700_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.2951","article-title":"Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing","volume":"32","author":"Heckl","year":"2014","journal-title":"Nat Biotechnol"},{"key":"2025112416562028700_bib36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.stem.2017.07.015","article-title":"Multiplex CRISPR\/Cas9-based genome editing in human hematopoietic stem cells models clonal hematopoiesis and myeloid neoplasia","volume":"21","author":"Tothova","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2025112416562028700_bib37","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood.2020009103","article-title":"Modeling and targeting of erythroleukemia by hematopoietic genome editing","volume":"137","author":"Iacobucci","year":"2021","journal-title":"Blood"},{"key":"2025112416562028700_bib38","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416562028700_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41467-017-00210-6","article-title":"Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia","volume":"8","author":"Knittel","year":"2017","journal-title":"Nat Commun"},{"key":"2025112416562028700_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.2020005734","article-title":"Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1","volume":"137","author":"Kohlhaas","year":"2021","journal-title":"Blood"},{"key":"2025112416562028700_bib41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B Cell Receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"key":"2025112416562028700_bib42","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"key":"2025112416562028700_bib43","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter's transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2020","journal-title":"Blood"},{"key":"2025112416562028700_bib44","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"key":"2025112416562028700_bib45","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1093\/emboj\/18.24.7019","article-title":"Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif","volume":"18","author":"Hurlin","year":"1999","journal-title":"EMBO J"},{"key":"2025112416562028700_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2025112416562028700_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"key":"2025112416562028700_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood.2021012081","article-title":"SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma","volume":"139","author":"Wilke","year":"2022","journal-title":"Blood"},{"key":"2025112416562028700_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-10-604959","article-title":"Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia","volume":"126","author":"Rodriguez","year":"2015","journal-title":"Blood"},{"key":"2025112416562028700_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"key":"2025112416562028700_bib51","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"key":"2025112416562028700_bib52","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.celrep.2017.09.066","article-title":"A B cell regulome links notch to downstream oncogenic pathways in small B cell lymphomas","volume":"21","author":"Ryan","year":"2017","journal-title":"Cell Rep"},{"key":"2025112416562028700_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood-2020-138811","article-title":"Updated results from a phase I\/II study of duvelisib and venetoclax in patients with relapsed and refractory CLL\/SLL or Richter's syndrome","volume":"136","author":"Crombie","year":"2020","journal-title":"Blood"},{"key":"2025112416562028700_bib54","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/leu.2015.305","article-title":"Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo","volume":"30","author":"Hanna","year":"2016","journal-title":"Leukemia"},{"key":"2025112416562028700_bib55","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/bloodadvances.2020003795","article-title":"CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Emu-TCL1 mice through a CD40L-independent mechanism","volume":"5","author":"Grioni","year":"2021","journal-title":"Blood Adv"},{"key":"2025112416562028700_bib56","doi-asserted-by":"crossref","first-page":"e121438","DOI":"10.1172\/jci.insight.121438","article-title":"Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies","volume":"3","author":"Ten Hacken","year":"2018","journal-title":"JCI Insight"},{"key":"2025112416562028700_bib57","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"2025112416562028700_bib58","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"2025112416562028700_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"Ghia","year":"2007","journal-title":"Leukemia"},{"key":"2025112416562028700_bib60","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1158\/1078-0432.CCR-08-2057","article-title":"mTOR inhibitor RAD001 (everolimus) has antiangiogenic\/vascular properties distinct from a VEGFR tyrosine kinase inhibitor","volume":"15","author":"Lane","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2025112416562028700_bib61","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ccell.2018.11.001","article-title":"Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia","volume":"34","author":"Ott","year":"2018","journal-title":"Cancer Cell"},{"key":"2025112416562028700_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-016-2285-8","article-title":"Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma","volume":"131","author":"Kurokawa","year":"2017","journal-title":"J Neurooncol"},{"key":"2025112416562028700_bib63","doi-asserted-by":"crossref","first-page":"15916","DOI":"10.1038\/ncomms15916","article-title":"CDK4\/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers","volume":"8","author":"Vijayaraghavan","year":"2017","journal-title":"Nat Commun"},{"key":"2025112416562028700_bib64","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood-2017-08-802470","article-title":"Activity of the PI3K-delta, gamma inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma","volume":"131","author":"Horwitz","year":"2018","journal-title":"Blood"},{"key":"2025112416562028700_bib65","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41596-019-0195-x","article-title":"RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis","volume":"14","author":"Li","year":"2019","journal-title":"Nat Protoc"},{"key":"2025112416562028700_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"2025112416562028700_bib67","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025112416562028700_bib68","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112416562028700_bib69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","article-title":"ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis","volume":"53","author":"Granja","year":"2021","journal-title":"Nat Genet"},{"key":"2025112416562028700_bib70","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2025112416562028700_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2025112416562028700_bib72","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2025112416562028700_bib73","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nmeth.4401","article-title":"chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data","volume":"14","author":"Schep","year":"2017","journal-title":"Nat Methods"},{"key":"2025112416562028700_bib74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"key":"2025112416562028700_bib75","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-22-0082\/3229557\/bcd-22-0082.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-22-0082\/3267134\/bcd-22-0082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/2\/150\/3277580\/150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/4\/2\/150\/3277580\/150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:56:41Z","timestamp":1764021401000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/4\/2\/150\/718388\/In-Vivo-Modeling-of-CLL-Transformation-to-Richter"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,12,6]]},"published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-22-0082","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.6551159.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22546352","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22546352.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22546355","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6551159","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.22546355.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.30698535","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.30698538","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]}}}